A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

BACKGROUND: Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine. Whether hydroxychloroquine can prevent symptomatic infection after SARS-CoV-2 exposu...

Descripción completa

Detalles Bibliográficos
Autores principales: Boulware, David R., Pullen, Matthew F., Bangdiwala, Ananta S., Pastick, Katelyn A., Lofgren, Sarah M., Okafor, Elizabeth C., Skipper, Caleb P., Nascene, Alanna A., Nicol, Melanie R., Abassi, Mahsa, Engen, Nicole W., Cheng, Matthew P., LaBar, Derek, Lother, Sylvain A., MacKenzie, Lauren J., Drobot, Glen, Marten, Nicole, Zarychanski, Ryan, Kelly, Lauren E., Schwartz, Ilan S., McDonald, Emily G., Rajasingham, Radha, Lee, Todd C., Hullsiek, Kathy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289276/
https://www.ncbi.nlm.nih.gov/pubmed/32492293
http://dx.doi.org/10.1056/NEJMoa2016638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289276/
https://www.ncbi.nlm.nih.gov/pubmed/32492293
http://dx.doi.org/10.1056/NEJMoa2016638

Ejemplares similares